DDW 2022: Guselkumab Shows Promise in Moderately to Severely Active Ulcerative Colitis
The 200 mg and 400 mg doses offered similar clinical benefits
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The 200 mg and 400 mg doses offered similar clinical benefits
Only registered members have full access to PracticeUpdate content.